Meto's resources on metabolic syndrome and fatty liver disease provide relevant context for why VAT reduction translates to systemic metabolic benefit
2003, 34 (Suppl 3): 138-139
"Novel therapy for myocardial infarction: can HGF/Met be beneficial?"
doi: 10.3389/fonc.2022.891619 Received 08 March 2022 Accepted 09 June 2022 Published 07 July 2022 Volume 12 - 2022 Edited by Francesco Schettini, Institut de Recerca Biomdica August Pi i Sunyer (IDIBAPS), Spain Reviewed by Yaping Shao, Dalian Medical University, China
It is believed that OS, due to decreased GSH availability in the brain, is the major responsible of mitochondrial complex I activity inhibition
S dng kt hp vitamin B9 vi thuc h huyt p c th gim huyt p tt hn so vi ch s dng thuc